.jpeg)
2026-04-29 06:37:21
Loargys(Pegzilarginase-nbln) is a pegylated arginase replacement therapy for the long-term management of arginase 1 deficiency. This guide provides detailed information on pre-treatment preparation, dose adjustment and monitoring requirements during treatment, and standardized home subcutaneous injection procedures to help patients and healthcare providers use this medication safely and effectively.
2026-04-03 06:19:35
Cabergoline is a highly selective long-acting dopamine D2 receptor agonist, the first-line treatment for hyperprolactinemia (HPRL), pituitary prolactinoma, and physiological lactation suppression. Its core clinical dosing strategy follows low-dose initiation with gradual individualized titration. This article details its full clinical specifications, including dosing regimens, dose adjustment principles, indication-specific treatment duration, and post-discontinuation monitoring.
